AWM
VKTX icon

Activest Wealth Management’s Viking Therapeutics VKTX Stock Holding History

Activest Wealth Management’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$58.9K Buy
1,511
+40
+3% +$1.29K 0.01% 248
2026
Q1 		$47.9K Buy
1,471
+153
+12% +$4.92K 0.01% 341
2025
Q4 		$46.4K Sell
1,318
-777
-37% -$27.5K 0.01% 331
2025
Q3 		$55.1K Buy
2,095
+500
+31% +$14.9K 0.01% 251
2025
Q2 		$42.3K Sell
1,595
-13
-0.8% -$342 0.01% 228
2025
Q1 		$38.8K Sell
1,608
-557
-26% -$17.6K 0.01% 211
2024
Q4 		$87.1K Buy
2,165
+420
+24% +$23.9K 0.02% 133
2024
Q3 		$110K Buy
1,745
+500
+40% +$29.3K 0.03% 116
2024
Q2 		$66K Buy
+1,245
New +$81.6K 0.02% 149

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Activest Wealth Management's VKTX Position: Q2 2026 in Review

Activest Wealth Management increased its Viking Therapeutics (VKTX) stake by 2.7% in Q2 2026, buying an estimated $1.29K and bringing the position to 1,511 shares worth $58.9K. The position accounts for 0.01% of the portfolio, ranked #248.

Activest Wealth Management first reported a position in VKTX in Q2 2024 and has held it in 9 quarters since. The position peaked at $110K in Q3 2024. 436 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Activest Wealth Management held 1,511 shares of Viking Therapeutics worth $58.9K as of Q2 2026.
  • Activest Wealth Management bought 40 Viking Therapeutics shares in Q2 2026, an estimated $1.29K.
  • Viking Therapeutics made up 0.01% of Activest Wealth Management's portfolio in Q2 2026, its #248 holding.
  • Activest Wealth Management first reported a position in Viking Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • Activest Wealth Management's Viking Therapeutics position peaked at $110K in Q3 2024.
  • 436 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Activest Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.